Migraine is among the biggest reasons for disability worldwide. Current treatment options are sometimes inadequate for providing complete relief for sufferers. Research has found that a change in diet provides one more option sufferers are able to use in their attempt to have less headaches and migraines. Polyunsaturated fatty acids, which the body doesn’t produce,… Read More »
By Robert PreidtHealthDay Reporter MONDAY, May 3, 2021 (HealthDay News) — Certain blood types may increase a person’s risk of different health problems, a new study suggests. The research confirms some previous findings and reveals new links between blood types and diseases, according to the authors of the study published April 27 in the journal… Read More »
A study by researchers at Rutgers University in New Brunswick, New Jersey, published in the journal Pediatrics found that children are increasingly being prescribed drugs that are not approved by the Food and Drug Administration (FDA) for the conditions they are trying to treat, reports Rutgers Today. The FDA describes the use of a drug… Read More »
Scientists have identified an enzyme that is a “master regulator” of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development of new pharmaceuticals. As reported in Nature Communications, a global research team led by the University of Bristol studied how the activity… Read More »
FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections Print this page ADELAIDE, Australia, Dec. 11, 2018 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Tolsura™ (SUBA®-itraconazole) 65mg capsules. Tolsura is a… Read More »